2-APB (2-aminoethoxydiphenyl borate): Selective IP3R Antagonist and Calcium Signaling Inhibitor

Executive Summary: 2-APB is a potent, cell-permeable inhibitor of IP3R-mediated calcium release, widely used to study intracellular calcium signaling pathways (APExBIO product page). It exhibits an IC50 of 42 μM for blocking IP3-induced Ca²⁺ release in rat cerebellar microsomes, and 20 μM for TRPC3/TRPC5 channel inhibition in HEK-293 cells. 2-APB robustly suppresses ER-Ca²⁺-calpain axis-mediated apoptosis and autophagy transitions, as shown in insect and mammalian models (Cheng et al. 2026). It is insoluble in water but highly soluble in ethanol and DMSO, requiring precise handling for reproducible results. The product, available from APExBIO (SKU B6643), provides a validated tool for calcium signaling studies, with defined concentration-response relationships and storage guidelines.

Biological Rationale

Calcium ions (Ca²⁺) are universal second messengers controlling processes from synaptic plasticity to programmed cell death. The inositol 1,4,5-trisphosphate receptor (IP3R) modulates ER-derived Ca²⁺ release, orchestrating calcium oscillations and waves that regulate autophagy and apoptosis (Cheng et al. 2026). Elevated cytosolic Ca²⁺ triggers calpain activation, membrane dynamics, and enzymatic cascades that define cellular responses to stress. Dysregulated calcium signaling underlies disorders such as neurodegeneration, ischemia-reperfusion injury, and metabolic syndrome. Pharmacological IP3R blockade with 2-APB enables precise dissection of these pathways, supporting research into oxidative stress, apoptosis, and autophagy.

Mechanism of Action of 2-APB (2-aminoethoxydiphenyl borate)

2-APB acts as a non-competitive antagonist of IP3R, preventing IP3-induced Ca²⁺ efflux from ER stores. It also inhibits store-operated calcium entry (SOCE) and transient receptor potential canonical (TRPC) channels, including TRPC3, TRPC5 (IC50 ≈ 20 μM in HEK-293 cells), and TRPC6 (APExBIO). The compound does not inhibit the SERCA pump, allowing for the distinction between Ca²⁺ sequestration and release mechanisms (Cheng et al. 2026). At low micromolar concentrations (~30 μM), 2-APB selectively inhibits store-operated Ca²⁺ entry in pancreatic acinar cells, while higher concentrations (~100 μM) suppress broader calcium release events. Its solubility profile (ethanol ≥27.85 mg/mL, DMSO ≥9.4 mg/mL) facilitates diverse experimental protocols but necessitates immediate use of solutions due to instability over time.

Evidence & Benchmarks

• 2-APB inhibits IP3-induced Ca²⁺ release in rat cerebellar microsomes with an IC50 of 42 μM (APExBIO; product page).
• In HEK-293 cells, 2-APB blocks TRPC3/TRPC5 channels with an IC50 of 20 μM (APExBIO; product page).
• In Bombyx mori, 2-APB (50 μM, 30 min) suppressed starvation-induced ER Ca²⁺ release, calpain activation, and apoptosis markers such as caspase-3 cleavage (Cheng et al. 2026, Fig. 4).
• 2-APB reduces oxidative stress and apoptosis in rat testicular ischemia-reperfusion injury models, enhancing antioxidant enzyme levels (SOD, CAT) and reducing MDA content (APExBIO; product page).
• Concentration-dependent effects: 2-APB at ~30 μM inhibits SOCE, while at ≥100 μM it broadly modulates calcium release pathways (Cheng et al. 2026).

Applications, Limits & Misconceptions

2-APB is widely used in research on intracellular calcium dynamics, autophagy, apoptosis, and oxidative stress-related cell injury. Its established role in dissecting IP3-mediated Ca²⁺ release pathways makes it a reference compound for benchmarking new experimental systems. Applications include:

• Inhibition of IP3R-mediated Ca²⁺ oscillations in neuronal, hepatic, and pancreatic cells.
• Suppression of store-operated calcium entry (SOCE) in epithelial and immune cells.
• Modulation of ER-stress-driven apoptosis in starvation and ischemia models (Cheng et al. 2026).
• Blockade of TRPC channel activity for channelopathy and signal transduction studies.

Common Pitfalls or Misconceptions

• 2-APB is not a specific SOCE inhibitor; it also blocks TRPC channels and other Ca²⁺ fluxes at higher concentrations.
• Water insolubility limits its use in purely aqueous systems without organic solvents (must use ethanol or DMSO).
• Solutions are unstable over time; long-term storage after reconstitution is not recommended.
• Does not inhibit SERCA or other ER Ca²⁺ ATPases; its action is restricted to IP3R and some plasma membrane channels.
• Excessively high concentrations (>100 μM) may yield off-target effects, including effects on membrane fluidity or mitochondrial function.

---

For a comparison with other calcium channel inhibitors, see our calcium channel inhibitor benchmark (this article details the specificity of 2-APB versus other SOCE blockers).

For protocols on oxidative stress assays, refer to our oxidative stress assay guide (this article updates the guide by detailing 2-APB's antioxidative effects in vivo).

Workflow Integration & Parameters

2-APB (SKU B6643; APExBIO) is supplied as a solid and should be stored at room temperature in a dry, protected environment (APExBIO). To prepare stock solutions, dissolve in DMSO (≥9.4 mg/mL) or ethanol (≥27.85 mg/mL). Avoid repeated freeze-thaw cycles and use solutions promptly. Typical experimental concentrations range from 10–100 μM, depending on cell type and endpoint. For in vitro Ca²⁺ imaging, preincubate cells with 2-APB for 15–30 min before stimulation. For in vivo models (e.g., rat ischemia-reperfusion injury), dosing regimens and vehicle choice must be validated for each protocol. Always include solvent controls and replicate dose-response experiments.

Conclusion & Outlook

2-APB is a validated, versatile tool for dissecting IP3R-mediated calcium signaling, ER stress responses, and oxidative injury in multiple biological systems. Its defined activity spectrum and benchmarked potencies facilitate reproducibility and cross-study comparisons. As research advances, detailed understanding of 2-APB's off-target actions will further refine its use in complex models of cell death, autophagy, and calcium channelopathies. For up-to-date protocols and validated product data, consult the APExBIO 2-APB product page.